Camrelizumab, Pegaspargase and Apatinib With Radiation Therapy for Stage IE/IIE ENKTL

Clinical trial NCT04366128 · COMPLETED

Trial details

NCT number: NCT04366128
Sponsor: Rong Tao
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type

Start date: 2020-04-25
Primary completion: 2024-12-30
Enrollment: 61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.